1	Institut	NNP	2	nn
2	Merieux	NNP	3	nn
3	S.A.	NNP	6	nsubj
4	of	IN	3	prep
5	France	NNP	4	pobj
6	said	VBD	0	root
7	the	DT	9	det
8	Canadian	JJ	9	amod
9	government	NN	10	nsubj
10	raised	VBD	6	ccomp
11	an	DT	12	det
12	obstacle	NN	10	dobj
13	to	TO	12	prep
14	its	PRP$	16	poss
15	proposed	JJ	16	amod
16	acquisition	NN	13	pobj
17	of	IN	16	prep
18	Connaught	NNP	19	nn
19	BioSciences	NNP	20	nn
20	Inc.	NNP	17	pobj
21	for	IN	16	prep
22	942	CD	23	number
23	million	CD	25	num
24	Canadian	JJ	25	amod
25	dollars	NNS	21	pobj
26	-LRB-	-LRB-	27	punct
27	US$	$	25	dep
28	801.6	CD	27	number
29	million	CD	27	number
30	-RRB-	-RRB-	27	punct
31	.	.	6	punct

1	Merieux	NNP	2	nsubj
2	said	VBD	0	root
3	the	DT	4	det
4	government	NN	6	poss
5	's	POS	4	possessive
6	minister	NN	13	nsubj
7	of	IN	6	prep
8	industry	NN	7	pobj
9	,	,	8	punct
10	science	NN	8	conj
11	and	CC	8	cc
12	technology	NN	8	conj
13	told	VBD	2	ccomp
14	it	PRP	13	dobj
15	that	IN	19	complm
16	he	PRP	19	nsubj
17	was	VBD	19	cop
18	n't	RB	19	neg
19	convinced	JJ	13	ccomp
20	that	IN	24	complm
21	the	DT	22	det
22	purchase	NN	24	nsubj
23	is	VBZ	24	cop
24	likely	JJ	19	ccomp
25	to	TO	26	aux
26	be	VB	24	xcomp
27	of	IN	26	prep
28	``	``	27	punct
29	net	JJ	30	amod
30	benefit	NN	27	pobj
31	''	''	27	punct
32	to	TO	26	prep
33	Canada	NNP	32	pobj
34	.	.	2	punct

1	Canadian	JJ	3	amod
2	investment	NN	3	nn
3	rules	NNS	4	nsubj
4	require	VBP	0	root
5	that	IN	9	complm
6	big	JJ	8	amod
7	foreign	JJ	8	amod
8	takeovers	NNS	9	nsubj
9	meet	VB	4	ccomp
10	that	DT	11	det
11	standard	NN	9	dobj
12	.	.	4	punct

1	The	DT	3	det
2	French	JJ	3	amod
3	company	NN	4	nsubj
4	said	VBD	0	root
5	the	DT	6	det
6	government	NN	7	nsubj
7	gave	VBD	4	ccomp
8	it	PRP	7	iobj
9	30	CD	10	num
10	days	NNS	7	dobj
11	in	IN	14	rel
12	which	WDT	11	pobj
13	to	TO	14	aux
14	submit	VB	10	infmod
15	information	NN	14	dobj
16	to	TO	18	aux
17	further	RB	18	advmod
18	support	VB	15	infmod
19	its	PRP$	21	poss
20	takeover	NN	21	nn
21	plan	NN	18	dobj
22	.	.	4	punct

1	Both	DT	2	det
2	Merieux	NNP	11	nsubj
3	and	CC	2	cc
4	Connaught	NNP	2	conj
5	are	VBP	11	cop
6	biotechnology	NN	7	nn
7	research	NN	11	nn
8	and	CC	7	cc
9	vaccine	NN	10	nn
10	manufacturing	NN	7	conj
11	concerns	NNS	0	root
12	.	.	11	punct

1	The	DT	2	det
2	government	NN	4	poss
3	's	POS	2	possessive
4	action	NN	6	nsubj
5	was	VBD	6	cop
6	unusual	JJ	0	root
7	.	.	6	punct

1	Alan	NNP	2	nn
2	Nymark	NNP	16	nsubj
3	,	,	2	punct
4	executive	JJ	6	amod
5	vice	NN	6	nn
6	president	NN	2	appos
7	of	IN	6	prep
8	Investment	NNP	9	nn
9	Canada	NNP	7	pobj
10	,	,	9	punct
11	which	WDT	12	nsubj
12	oversees	VBZ	9	rcmod
13	foreign	JJ	14	amod
14	takeovers	NNS	12	dobj
15	,	,	9	punct
16	said	VBD	0	root
17	it	PRP	18	nsubj
18	marked	VBD	16	ccomp
19	the	DT	21	det
20	first	JJ	21	amod
21	time	NN	18	dobj
22	in	IN	21	prep
23	its	PRP$	25	poss
24	four-year	JJ	25	amod
25	history	NN	22	pobj
26	that	IN	30	advmod
27	the	DT	28	det
28	agency	NN	30	nsubj
29	has	VBZ	30	aux
30	made	VBN	21	dep
31	an	DT	34	det
32	adverse	JJ	34	amod
33	net-benefit	JJ	34	amod
34	decision	NN	30	dobj
35	about	IN	34	prep
36	the	DT	37	det
37	acquisition	NN	35	pobj
38	of	IN	37	prep
39	a	DT	42	det
40	publicly	RB	41	advmod
41	traded	VBN	42	amod
42	company	NN	38	pobj
43	.	.	16	punct

1	He	PRP	2	nsubj
2	said	VBD	0	root
3	it	PRP	5	nsubj
4	has	VBZ	5	aux
5	reached	VBN	2	ccomp
6	the	DT	8	det
7	same	JJ	8	amod
8	conclusions	NNS	5	dobj
9	about	IN	8	prep
10	some	DT	11	det
11	attempts	NNS	9	pobj
12	to	TO	13	aux
13	buy	VB	11	infmod
14	closely	RB	15	advmod
15	held	VBN	13	acomp
16	concerns	NNS	13	dep
17	,	,	5	punct
18	but	CC	5	cc
19	eventually	RB	20	advmod
20	allowed	VBD	5	conj
21	those	DT	22	det
22	acquisitions	NNS	24	nsubj
23	to	TO	24	aux
24	proceed	VB	20	xcomp
25	.	.	2	punct

1	``	``	19	punct
2	This	DT	6	nsubj
3	is	VBZ	6	cop
4	n't	RB	6	neg
5	a	DT	6	det
6	change	NN	19	ccomp
7	in	IN	6	prep
8	government	NN	9	nn
9	policy	NN	7	pobj
10	;	:	6	punct
11	this	DT	12	det
12	provision	NN	15	nsubjpass
13	has	VBZ	15	aux
14	been	VBN	15	auxpass
15	used	VBN	6	parataxis
16	before	RB	15	advmod
17	,	,	19	punct
18	''	''	19	punct
19	said	VBD	0	root
20	Jodi	NNP	21	nn
21	Redmond	NNP	19	nsubj
22	,	,	21	punct
23	press	NN	24	nn
24	secretary	NN	21	appos
25	for	IN	24	prep
26	Harvie	NNP	27	nn
27	Andre	NNP	25	pobj
28	,	,	27	punct
29	Canada	NNP	31	poss
30	's	POS	29	possessive
31	minister	NN	27	appos
32	of	IN	31	prep
33	industry	NN	32	pobj
34	,	,	33	punct
35	science	NN	33	conj
36	and	CC	33	cc
37	technology	NN	33	conj
38	.	.	19	punct

1	Mr.	NNP	2	nn
2	Andre	NNP	3	nsubj
3	issued	VBD	0	root
4	the	DT	5	det
5	ruling	NN	3	dobj
6	based	VBN	3	prep
7	on	IN	6	pcomp
8	a	DT	9	det
9	recommendation	NN	7	pobj
10	by	IN	9	prep
11	Investment	NNP	12	nn
12	Canada	NNP	10	pobj
13	.	.	3	punct

1	Spokesmen	NNP	6	nsubj
2	for	IN	1	prep
3	Merieux	NNP	2	pobj
4	and	CC	3	cc
5	Connaught	NNP	3	conj
6	said	VBD	0	root
7	they	PRP	11	nsubjpass
8	had	VBD	11	aux
9	n't	RB	11	neg
10	been	VBN	11	auxpass
11	informed	VBN	6	ccomp
12	of	IN	11	prep
13	specific	JJ	14	amod
14	areas	NNS	12	pobj
15	of	IN	14	prep
16	concern	NN	15	pobj
17	by	IN	11	prep
18	either	CC	20	preconj
19	the	DT	20	det
20	government	NN	17	pobj
21	or	CC	20	cc
22	Investment	NNP	23	nn
23	Canada	NNP	20	conj
24	,	,	6	punct
25	but	CC	6	cc
26	added	VBD	6	conj
27	they	PRP	28	nsubj
28	hope	VBP	26	ccomp
29	to	TO	30	aux
30	have	VB	28	xcomp
31	more	JJR	32	amod
32	information	NN	30	dobj
33	early	RB	35	advmod
34	this	DT	35	det
35	week	NN	30	tmod
36	.	.	6	punct

1	Investment	NNP	2	nn
2	Canada	NNP	3	nsubj
3	declined	VBD	0	root
4	to	TO	5	aux
5	comment	VB	3	xcomp
6	on	IN	5	prep
7	the	DT	8	det
8	reasons	NNS	6	pobj
9	for	IN	8	prep
10	the	DT	12	det
11	government	NN	12	nn
12	decision	NN	9	pobj
13	.	.	3	punct

1	Viren	NNP	2	nn
2	Mehta	NNP	19	nsubj
3	,	,	2	punct
4	a	DT	5	det
5	partner	NN	2	appos
6	with	IN	5	prep
7	Mehta	NNP	6	pobj
8	&	CC	7	cc
9	Isaly	NNP	7	conj
10	,	,	7	punct
11	a	DT	17	det
12	New	NNP	13	amod
13	York-based	JJ	17	amod
14	pharmaceutical	JJ	15	amod
15	industry	NN	17	nn
16	research	NN	17	nn
17	firm	NN	7	appos
18	,	,	7	punct
19	said	VBD	0	root
20	the	DT	21	det
21	government	NN	23	poss
22	's	POS	21	possessive
23	ruling	NN	26	nsubj
24	was	VBD	26	cop
25	n't	RB	26	neg
26	unexpected	JJ	19	ccomp
27	.	.	19	punct

1	``	``	25	punct
2	This	DT	8	nsubj
3	has	VBZ	8	aux
4	become	VBN	8	cop
5	a	DT	8	det
6	very	RB	7	advmod
7	politicized	JJ	8	amod
8	deal	NN	25	ccomp
9	,	,	8	punct
10	concerning	VBG	8	prep
11	Canada	NNP	20	poss
12	's	POS	11	possessive
13	only	JJ	20	amod
14	large	JJ	20	amod
15	,	,	20	punct
16	world-class	JJ	20	amod
17	bio-research	NN	20	nn
18	or	CC	17	cc
19	pharmaceutical	JJ	17	conj
20	company	NN	10	pobj
21	,	,	25	punct
22	''	''	25	punct
23	Mr.	NNP	24	nn
24	Mehta	NNP	25	nsubj
25	said	VBD	0	root
26	.	.	25	punct

1	Mr.	NNP	2	nn
2	Mehta	NNP	3	nsubj
3	said	VBD	0	root
4	the	DT	5	det
5	move	NN	20	nsubj
6	that	WDT	8	nsubj
7	could	MD	8	aux
8	allow	VB	5	rcmod
9	the	DT	10	det
10	transaction	NN	12	nsubj
11	to	TO	12	aux
12	go	VB	8	xcomp
13	ahead	RB	12	advmod
14	as	IN	15	mark
15	planned	VBN	12	advcl
16	could	MD	20	aux
17	be	VB	20	cop
18	an	DT	20	det
19	out-of-court	JJ	20	amod
20	settlement	NN	3	ccomp
21	of	IN	20	prep
22	Connaught	NNP	24	poss
23	's	POS	22	possessive
24	dispute	NN	21	pobj
25	with	IN	24	prep
26	the	DT	27	det
27	University	NNP	25	pobj
28	of	IN	27	prep
29	Toronto	NNP	28	pobj
30	.	.	3	punct

1	The	DT	2	det
2	University	NNP	4	nsubj
3	is	VBZ	4	aux
4	seeking	VBG	0	root
5	to	TO	6	aux
6	block	VB	4	xcomp
7	the	DT	8	det
8	acquisition	NN	6	dobj
9	of	IN	8	prep
10	Connaught	NNP	9	pobj
11	by	IN	8	prep
12	foreign	JJ	13	amod
13	interests	NNS	11	pobj
14	,	,	4	punct
15	citing	VBG	4	xcomp
16	concerns	NNS	15	dobj
17	about	IN	16	prep
18	the	DT	19	det
19	amount	NN	17	pobj
20	of	IN	19	prep
21	research	NN	20	pobj
22	that	WDT	25	nsubjpass
23	would	MD	25	aux
24	be	VB	25	auxpass
25	done	VBN	19	rcmod
26	in	IN	25	prep
27	Canada	NNP	26	pobj
28	.	.	4	punct

1	The	DT	2	det
2	university	NN	4	nsubj
3	is	VBZ	4	aux
4	considering	VBG	0	root
5	a	DT	7	det
6	settlement	NN	7	nn
7	proposal	NN	4	dobj
8	made	VBN	7	partmod
9	by	IN	8	prep
10	Connaught	NNP	9	pobj
11	.	.	4	punct

1	While	IN	5	mark
2	neither	DT	3	det
3	side	NN	5	nsubj
4	will	MD	5	aux
5	disclose	VB	11	advcl
6	its	PRP$	7	poss
7	contents	NNS	5	dobj
8	,	,	11	punct
9	Mr.	NNP	10	nn
10	Mehta	NNP	11	nsubj
11	expects	VBZ	0	root
12	it	PRP	14	nsubj
13	to	TO	14	aux
14	contain	VB	11	xcomp
15	more	RBR	16	advmod
16	specific	JJ	17	amod
17	guarantees	NNS	14	dobj
18	on	IN	17	prep
19	research	NN	22	nn
20	and	CC	19	cc
21	development	NN	19	conj
22	spending	NN	23	nn
23	levels	NNS	18	pobj
24	in	IN	23	prep
25	Canada	NNP	24	pobj
26	than	IN	28	mark
27	Merieux	NNP	28	nsubj
28	offered	VBD	17	dep
29	to	TO	28	prep
30	Investment	NNP	31	nn
31	Canada	NNP	29	pobj
32	.	.	11	punct

1	Some	DT	2	det
2	analysts	NNS	14	nsubj
3	,	,	2	punct
4	such	JJ	5	mwe
5	as	IN	2	prep
6	Murray	NNP	7	nn
7	Grossner	NNP	5	pobj
8	of	IN	7	prep
9	Toronto-based	JJ	12	amod
10	Richardson	NNP	11	nn
11	Greenshields	NNP	12	nn
12	Inc.	NNP	8	pobj
13	,	,	2	punct
14	believe	VBP	0	root
15	the	DT	17	det
16	government	NN	17	nn
17	ruling	NN	18	nsubj
18	leaves	VBZ	14	ccomp
19	the	DT	20	det
20	door	NN	21	nsubj
21	open	JJ	18	xcomp
22	for	IN	21	prep
23	other	JJ	24	amod
24	bidders	NNS	22	pobj
25	,	,	24	punct
26	such	JJ	27	mwe
27	as	IN	24	prep
28	Switzerland	NNP	30	poss
29	's	POS	28	possessive
30	Ciba-Geigy	NNP	27	pobj
31	and	CC	30	cc
32	Chiron	NNP	33	nn
33	Corp.	NNP	30	conj
34	of	IN	33	prep
35	Emeryville	NNP	34	pobj
36	,	,	35	punct
37	Calif	NNP	35	appos
38	.	.	14	punct

1	Officials	NNS	20	nsubjpass
2	for	IN	1	prep
3	the	DT	5	det
4	two	CD	5	num
5	concerns	NNS	2	pobj
6	,	,	5	punct
7	which	WDT	9	nsubj
8	are	VBP	9	aux
9	bidding	VBG	5	rcmod
10	C$	$	9	dobj
11	30	CD	10	num
12	a	DT	13	det
13	share	NN	10	npadvmod
14	for	IN	9	prep
15	Connaught	NNP	14	pobj
16	,	,	20	punct
17	could	MD	20	aux
18	n't	RB	20	neg
19	be	VB	20	auxpass
20	reached	VBN	0	root
21	for	IN	20	prep
22	comment	NN	21	pobj
23	.	.	20	punct

1	French	JJ	2	amod
2	state-owned	JJ	4	amod
3	Rhone-Poulenc	NNP	4	nn
4	S.A.	NNP	5	nsubj
5	holds	VBZ	0	root
6	51	CD	7	num
7	%	NN	5	dobj
8	of	IN	7	prep
9	Merieux	NNP	8	pobj
10	.	.	5	punct


